BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1736494)

  • 1. Role of citric acid in primary hyperparathyroidism with renal lithiasis.
    Alvarez-Arroyo MV; Traba ML; Rapado A; de la Piedra C
    Urol Res; 1992; 20(1):88-90. PubMed ID: 1736494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.
    Schwille PO; Scholz D; Schwille K; Leutschaft R; Goldberg I; Sigel A
    Nephron; 1982; 31(3):194-202. PubMed ID: 7121665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal lithiasis in idiopathic hypercalciuria and primary hyperparathyroidism].
    Burckhardt P
    Ann Med Interne (Paris); 1986; 137(3):216-9. PubMed ID: 3767188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypercalciuria, primary hyperparathyroidism and calcium nephrolithiasis].
    Ivanov I
    Vutr Boles; 1984; 23(2):1-7. PubMed ID: 6331011
    [No Abstract]   [Full Text] [Related]  

  • 5. URINARY EXCRETION OF CALCIUM AND CITRATE IN NORMAL INDIVIDUALS AND STONE FORMERS WITH VARIATION IN CALCIUM INTAKE.
    MCINTOSH HW; SERAGLIA M
    Can Med Assoc J; 1963 Dec; 89(24):1242-3. PubMed ID: 14084708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical factors important to calcium nephrolithiasis: evidence for impaired hydroxycarboxylic acid absorption causing hyperoxaluria.
    Cowley DM; McWhinney BC; Brown JM; Chalmers AH
    Clin Chem; 1987 Feb; 33(2 Pt 1):243-7. PubMed ID: 3802507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Normocalcemic nephrolithiasis and primary hyperparathyroidism].
    Buser U; Lauffenburger T; Wacker HR; Hagmaier V; Rutishauser G; Haas HG
    Helv Chir Acta; 1978 Jul; 45(3):263-6. PubMed ID: 701062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypocitraturia as a pathogenic risk factor in the mixed (calcium oxalate/uric acid) renal stones.
    Alvarez Arroyo MV; Traba ML; Rapado A
    Urol Int; 1992; 48(3):342-6. PubMed ID: 1589930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How to differentiate hyperparathyroid patients among intermittent hypercalcemic urinary stone formers: a combined use of immunoreactive parathyroid hormone and nephrogenous adenosine 3',5'-monophosphate.
    Kitamura T; Tanaka M; Abe K; Niijima T
    J Urol; 1980 Mar; 123(3):328-34. PubMed ID: 7359629
    [No Abstract]   [Full Text] [Related]  

  • 11. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. THE RENAL CLEARANCE OF CITRATE IN MAN.
    CANARY JJ; MELONI CR; CLIVE D; GROSSMAN E
    Metabolism; 1964 Jan; 13():21-30. PubMed ID: 14105456
    [No Abstract]   [Full Text] [Related]  

  • 13. A lack of unique pathophysiologic background for nephrolithiasis of primary hyperparathyroidism.
    Pak CY; Nicar MJ; Peterson R; Zerwekh JE; Snyder W
    J Clin Endocrinol Metab; 1981 Sep; 53(3):536-42. PubMed ID: 7263839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of hyperparathyroidism and recurrent renal lithiasis].
    Bernheim J; Pozet N; Zech P; Archimbaud JP; Dubernard JM; Traeger J; Perrin J
    J Urol Nephrol (Paris); 1975; 81(10-11):824-30. PubMed ID: 1219134
    [No Abstract]   [Full Text] [Related]  

  • 15. Infrequency of primary hyperparathyroidism in renal stone formers.
    Fuss M; Pepersack T; Corvilain J; Vandewalle JC; Van Geertruyden J; Simon J; Kinnaert P
    Br J Urol; 1988 Jul; 62(1):4-6. PubMed ID: 3408867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic study of hyperparathyroid and other renal stone formers using a very low intake of calcium and magnesium.
    Keynes WM; Barnes BA; Gordon E; Cope O
    Br J Surg; 1969 Aug; 56(8):624. PubMed ID: 5797755
    [No Abstract]   [Full Text] [Related]  

  • 17. [Nephrolithiasis induced by hyperparathyroidism].
    Marković V; Macura D
    Srp Arh Celok Lek; 1974 Feb; 102(2):101-10. PubMed ID: 4410206
    [No Abstract]   [Full Text] [Related]  

  • 18. [Citrate and kidney stones].
    Osther PJ
    Ugeskr Laeger; 1993 Nov; 155(47):3835-9. PubMed ID: 8256384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and glucose load studies in uric acid, oxalic and hyperparathyroid stone formers.
    Schwille PO; Scholz D; Hagemann G; Sigel A
    Adv Exp Med Biol; 1974; 41():485-94. PubMed ID: 4832572
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hypercalciuric and hyperparathyroid renal lithiasis].
    Rapado A; de la Calle H; Castrillo JM; Mancha A; Traba ML; Cifuentes Delatte L
    Minerva Med; 1976 Nov; 67(55):3573-81. PubMed ID: 995303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.